Literature DB >> 23712676

Relationship between the urinary excretion mechanisms of drugs and their physicochemical properties.

Sumito Ito1, Hirotaka Ando, Atsushi Ose, Yoshiaki Kitamura, Tomohiro Ando, Hiroyuki Kusuhara, Yuichi Sugiyama.   

Abstract

The purpose of this study was to clarify the relationship between the physicochemical properties of drugs and their urinary excretion mechanisms. Three hundred twenty-five drugs were classified into the reabsorption, intermediate, and secretion types based on their ratio of renal clearance to protein-unbound fraction glomerular filtration rate. Fifty percent of ionized and neutral drugs were the secretion and reabsorption types, respectively. The mean molecular weight of the neutral drugs was slightly smaller than those of the ionized drugs (296 vs. 330-368 g/mol). The reabsorption-type anionic drugs were characterized by their low molecular weights (mean value 269 g/mol) and the logarithmic measure of the acid dissociation constants (pKa s) greater than 4.5, whereas the secretion-type anionic drugs all had pKa s below 4.5. Cationic drugs with pKa s lower than 8.0 tended to be the reabsorption type. Some cationic drugs were classified as the secretion type, despite their high molecular weights (734-811 g/mol) and high log P values (3.1-5.3). The organic anion transporter (OAT)1 and OAT3 substrates were all secretion-type drugs. The same trend was observed for the substrates of organic cation transporter 2, multidrug and toxin extrusion, multidrug resistance-associated protein 4, and multidrug resistance 1/breast cancer resistance protein, but substantial fractions of the substrates were categorized as the intermediate or reabsorption types (9%-38%). This work provides a clue to the renal elimination mechanism of new chemical entities during drug development.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  physicochemical; renal clearance; renal reabsorption; renal transport; transporters

Mesh:

Substances:

Year:  2013        PMID: 23712676     DOI: 10.1002/jps.23599

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

Review 1.  Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.

Authors:  Laurel K Mydock-McGrane; Thomas J Hannan; James W Janetka
Journal:  Expert Opin Drug Discov       Date:  2017-06-02       Impact factor: 6.098

2.  Predicting the Drug Clearance Pathway with Structural Descriptors.

Authors:  Navid Kaboudi; Ali Shayanfar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-02-11       Impact factor: 2.441

Review 3.  Veterinary Medicine Needs New Green Antimicrobial Drugs.

Authors:  Pierre-Louis Toutain; Aude A Ferran; Alain Bousquet-Melou; Ludovic Pelligand; Peter Lees
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

4.  Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.

Authors:  Daniel Scotcher; Christopher Jones; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  Eur J Pharm Sci       Date:  2016-03-28       Impact factor: 4.384

5.  Development of a Dynamic Physiologically Based Mechanistic Kidney Model to Predict Renal Clearance.

Authors:  Weize Huang; Nina Isoherranen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08-11

6.  Development of an in silico prediction system of human renal excretion and clearance from chemical structure information incorporating fraction unbound in plasma as a descriptor.

Authors:  Reiko Watanabe; Rikiya Ohashi; Tsuyoshi Esaki; Hitoshi Kawashima; Yayoi Natsume-Kitatani; Chioko Nagao; Kenji Mizuguchi
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.